Skip to main content
. 2022 Apr 17;14:25158414221090103. doi: 10.1177/25158414221090103

Table 2.

Factors associated with mean intra-procedural change of systolic blood pressure using linear regression analysis.

Univariate analysis Multivariable analysis
Co-efficient
(95% CI)
p value Co-efficient
(95% CI)
p value
Age 0.25
(0.02 to 0.47)
0.029 0.33
(0.11 to 0.55)
0.004
Gender −2.57
(−7.60 to 2.46)
0.316 −2.74
(−7.67 to 2.19)
0.274
Number of previous injections −0.27
(−1.0 to 0.45)
0.457 −0.63
(−1.35 to 0.09)
0.085
Systemic diagnosis
 Diabetes mellitus 0.34
(−4.98 to 5.67)
0.899 1.56
(−3.72 to 6.85)
0.561
 Hypertension −0.83
(−5.59 to 3.94)
0.733 0.71
(−4.15 to 5.58)
0.773
 CKD −5.97
(−17.27 to 5.32)
0.299 −3.07
(−14.37 to 8.22)
0.593
 Baseline SBP −0.25
(−0.38 to −0.12)
<0.001 −0.28
(−0.42 to −0.15)
<0.001
Ocular diagnosis
 BRVO 0.36
(−6.3 to 7.0)
0.915 8.77
(−4.2 to 21.8)
0.185
 CNVM −0.04
(−6.2 to 6.1)
0.989 8.43
(−4.3 to 21.2)
0.194
 CRVO −2.19
(−9.1 to 4.7)
0.531 6.58
(−6.6 to 19.7)
0.325
 NPDR 3.78
(−1.9 to 9.4)
0.189 11.38
(−1.1 to 23.9)
0.075
 NVG 4.25
(−9.0 to 17.5)
0.530 12.57
(−4.8 to 30.0)
0.156
 PCV −8.85
(−20.5 to 2.8)
0.137
 PDR −1.26
(−7.0 to 4.5)
0.667 −7.48
(−5.1 to 20.0)
0.242

BRVO, branch retinal vein occlusion; CI, confidence interval; CKD, chronic kidney disease; CNVM, choroidal neovascular membrane; CRVO, central retinal vein occlusion; NPDR, nonproliferative diabetic retinopathy; NVG, neovascular glaucoma; PCV, polypoidal choroidal vasculopathy; PDR, proliferative diabetic retinopathy; SBP, systolic blood pressure.

The significant values have been written in italics.